Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2CNS 1

Conditions

Glioblastoma 8Gliosarcoma 7Brain Neoplasms 5Central Nervous System Neoplasms 4Osteosarcoma 2Oligodendroglioma 2Glioma 2Astrocytoma 2Untreated Childhood Anaplastic Astrocytoma 1Sarcoma, Synovial 1Sarcoma 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Meningioma 1Glioma, Subependymal 1

Interventions

Ifosfamide 30Methotrexate 29Doxorubicin 26Cyclophosphamide 24Cisplatin 22Filgrastim 18Etoposide 17Gemcitabine 16Leucovorin 14Magnetic Resonance Spectroscopy 11Temozolomide 10Specimen Handling 10cabozantinib 9apatinib 9X-Rays 9Carboplatin 9fludarabine 8Radiotherapy 8Nivolumab 8Neoadjuvant Therapy 8Irinotecan 8Granulocyte Colony-Stimulating Factor 8Drug Therapy 8Docetaxel 8Zoledronic Acid 7Vincristine 7Sirolimus 7Phantoms, Imaging 7Biopsy 7mifamurtide 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Osteosarcoma × Gefitinib × Sarcoma × Clear all
NCT07477457 2026-03-17

A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
45 enrolled
Sarcoma

Neoplasm Metastasis, Osteosarcoma

NCT00132158 2012-04-17

ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors

St. Jude Children's Research Hospital

Phase 1 Completed
19 enrolled
CNSSarcoma

Glioblastoma, Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡